Part II of this book has demonstrated that building synergies between health systems and industrial development is a complex process of reshaping the politics and political economy of the two systems. A key tool for building and sustaining health-industry relationships, as Smita Srinivas observes above and as some Part I chapters also emphasized, is procurement. Yet procurement remains under-researched and over-simplified as a technical, linear, ordering and delivery process (see Chapter 8), rather than an exercise in deepening and strengthening the domestic economy through market and non-market relationships building.
- Cash Flow
- Trade Credit
- Local Firm
- Public Procurement
- Cash Holding
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Procurement is then an integral part of health policy. However, it is of course also a part of industrial policy. This is because the way in which purchasing decisions are structured and regulated impact profoundly on the way in which production happens. Thus, consideration of the pros and cons associated with procurement regimes needs to be in terms, not only of whether immediate health policy priorities are achieved, but also in light of longer term sustainability of supply of innovative health products. Thus, price, value and innovation are closely interwoven. (Srinivas, 2012: 126)
Editors and Affiliations
© 2016 Joanna Chataway, Geoffrey Banda, Gavin Cochrane and Catriona Manville
About this chapter
Cite this chapter
Chataway, J., Banda, G., Cochrane, G., Manville, C. (2016). Innovative Procurement for Health and Industrial Development. In: Mackintosh, M., Banda, G., Tibandebage, P., Wamae, W. (eds) Making Medicines in Africa. International Political Economy Series. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-137-54647-0_14
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-137-57133-5
Online ISBN: 978-1-137-54647-0